论文部分内容阅读
Aim:Previous studies showed that circulating fibroblast growth factor-23(FGF23)is a new biomarker linked to cardiovascular and kidney diseases.Here,we explored the association between serum FGF23 and aging-related cardiovascular-renal parameters in a healthy Chinese population.